p 53 Codon 72 Polymorphism in Taiwanese Lung Cancer Patients : Association with Lung Cancer Susceptibility and Prognosis 1

An association between theBstUI (Pro/Pro) genotype of the p53 codon 72 polymorphism and lung cancer has been reported previously (X. Jin et al., Carcinogenesis (Lond.), 16: 2205–2208, 1995). However, the genotype distribution of p53codon 72 polymorphism as well as the association of this polymorphism with lung cancer risk and prognosis remain undefined in the Taiwanese population. Therefore, we investigated the genotype distribution ofp53 codon 72 polymorphism in 194 lung cancer patients and 152 noncancer controls. The genotype frequencies in Taiwanese noncancer controls were 0.56 (Arg) and 0.44 (Pro).x analysis indicated significant differences in genotype distribution ofp53 from other reports in Swedish (P < 0.001), Spanish (P< 0.001), Caucasians in the United States ( P 5 0.002), and African-Americans (P 5 0.027). In addition, our data suggest that the Pro allele of the p53 codon 72 polymorphism increased the risk of lung cancer among female Taiwanese. The female patients with genotypePro/Pro showed a significantly increased odds ratio (3.14; confidence interval, 1.48– 6.64; P 5 0.003) of having lung adenocarcinoma, compared with normal controls with the other genotypes. Patients with the Pro/Pro genotype had an odds ratio of 2.63 (confidence interval, 1.22–5.68; P 5 0.01) higher than those with the other genotypes to be diagnosed with lung cancer at the early ages. We further investigated the association of p53 codon 72 polymorphism with prognosis in 133 lung cancer patients. Patients with thePro/Pro genotype tended to have poorer prognosis than those with theArg/Pro genotype (P5 0.05, by the log-rank test). Our data suggested thatp53 codon 72 polymorphism may play a role in cancer susceptibility and prognosis in specific classes of lung cancer patients in Taiwan.

[1]  H. Lee,et al.  High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. , 1998, Cancer research.

[2]  A. Sood,et al.  The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis. , 1997, Cancer gene therapy.

[3]  J. Ribeiro,et al.  Relationship between radiation response and p53 status in human bladder cancer cells. , 1997, International journal of radiation biology.

[4]  J. Ribeiro,et al.  Studies of X-irradiated bladder cancer cell lines showing differences in p53 status: absence of a p53-dependent cell cycle checkpoint pathway. , 1996, Oncogene.

[5]  M. Oren,et al.  p53 in growth control and neoplasia. , 1996, Biochimica et biophysica acta.

[6]  C. Galán,et al.  Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  M. Lung,et al.  Detection and evaluation of p53 intron 2 polymorphism in lung carcinomas in Hong Kong , 1996, International journal of cancer.

[8]  M. Tagawa,et al.  Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. , 1996, Carcinogenesis.

[9]  M. Spitz,et al.  Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. , 1995, Carcinogenesis.

[10]  R. Birgander,et al.  P53 polymorphisms and haplotypes in lung cancer. , 1995, Carcinogenesis.

[11]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[12]  R. Birgander,et al.  Is p53 polymorphism maintained by natural selection? , 1994, Human heredity.

[13]  R. Hoover,et al.  Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. , 1994, Carcinogenesis.

[14]  L. Ger,et al.  Risk factors of lung cancer by histological category in Taiwan. , 1993, Anticancer research.

[15]  K. Nakachi,et al.  Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. , 1993, Cancer research.

[16]  K. Nakachi,et al.  Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. , 1993, Carcinogenesis.

[17]  R. Hoover,et al.  Allelic frequency of a p53 polymorphism in human lung cancer. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  A. Deisseroth,et al.  Polymorphism at codon 72 of the p53 gene in human acute myelogenous leukemia. , 1992, Gene.

[19]  R. Metcalf,et al.  p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. , 1991, Cancer research.

[20]  C. Mountain,et al.  A new international staging system for lung cancer. , 1987, Chest.

[21]  D. Pim,et al.  Primary structure polymorphism at amino acid residue 72 of human p53 , 1987, Molecular and cellular biology.

[22]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[23]  K. Luh,et al.  Epidemiologic characteristics and multiple risk factors of lung cancer in Taiwan. , 1990, Anticancer research.

[24]  J H Ho,et al.  Worldwide epidemiological patterns of lung cancer in nonsmokers. , 1990, International journal of epidemiology.